Subtopic Deep Dive

IL-17 Producing T Cell Plasticity
Research Guide

What is IL-17 Producing T Cell Plasticity?

IL-17 producing T cell plasticity refers to the transdifferentiation capacity of Th17 cells into regulatory T cells, Tr1 cells, Tfh cells, or cytotoxic lineages driven by inflammatory cues and epigenetic modifications in psoriasis pathogenesis.

Th17 cells, key IL-17 producers in psoriasis, exhibit plasticity by switching phenotypes under IL-23, IL-6, and TGF-β signals (Gaffen et al., 2014; 1477 citations). Studies show Th17 to Treg conversion during inflammation resolution (Gagliani et al., 2015; 770 citations). Over 10 papers from 2008-2022 document these shifts, with late plasticity in established lineages (Lee et al., 2009; 1021 citations).

Curated Papers

Key Challenges

Why It Matters

Th17 plasticity drives therapeutic resistance in psoriasis by enabling IL-17+ cells to evade IL-17/IL-23 blockers like secukinumab. Gagliani et al. (2015) demonstrated Th17-to-Treg transdifferentiation reduces inflammation, suggesting combination therapies targeting plasticity pathways. Lowes et al. (2014) linked plastic Th17/Th22 infiltrates to epidermal hyperplasia in psoriatic skin, informing biologics design. Mills (2022) highlighted IL-17+ plasticity in chronic autoimmunity, impacting treatments for 125 million psoriasis patients worldwide.

Key Research Challenges

Tracking Transdifferentiation Dynamics

Lineage tracing in vivo remains difficult due to transient epigenetic shifts during Th17 to Treg conversion. Gagliani et al. (2015) used fate-mapping but noted limitations in human psoriasis lesions. Single-cell RNA-seq is needed for real-time plasticity capture (Lowes et al., 2014).

Identifying Environmental Drivers

Cytokines like IL-23 drive plasticity, but specific triggers for Th17 to cytotoxic shifts are unclear. Yang et al. (2008) showed molecular antagonism between programs, yet psoriasis-specific cues lack definition. Lee et al. (2009) reported late plasticity influenced by unresolved inflammation.

Overcoming Therapeutic Resistance

Plastic Th17 cells sustain IL-17 production despite IL-23 inhibition. Gaffen et al. (2014) outlined axis testing, but resistance via subset switching persists. Mills (2022) emphasized pathology from persistent IL-17+ plasticity.

Essential Papers

Immunology of Psoriasis

Michelle A. Lowes, Mayte Suárez‐Fariñas, James G. Krueger · 2014 · Annual Review of Immunology · 1.5K citations

The skin is the front line of defense against insult and injury and contains many epidermal and immune elements that comprise the skin-associated lymphoid tissue (SALT). The reaction of these compo...

The IL-23–IL-17 immune axis: from mechanisms to therapeutic testing

Sarah L. Gaffen, Renu Jain, Abhishek V. Garg et al. · 2014 · Nature reviews. Immunology · 1.5K citations

A Validated Regulatory Network for Th17 Cell Specification

Maria Ciofani, Aviv Madar, Carolina Galan et al. · 2012 · Cell · 1.2K citations

Molecular Antagonism and Plasticity of Regulatory and Inflammatory T Cell Programs

Xuexian O. Yang, Roza Nurieva, Gustavo Martínez et al. · 2008 · Immunity · 1.1K citations

Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling

Stefanie Eyerich, Kilian Eyerich, Davide Pennino et al. · 2009 · Journal of Clinical Investigation · 1.0K citations

Th subsets are defined according to their production of lineage-indicating cytokines and functions. In this study, we have identified a subset of human Th cells that infiltrates the epidermis in in...

Late Developmental Plasticity in the T Helper 17 Lineage

Yun Kyung Lee, Henrietta Turner, Craig L. Maynard et al. · 2009 · Immunity · 1.0K citations

Interleukin-22: Immunobiology and Pathology

Jarrod A. Dudakov, Alan M. Hanash, Marcel R.M. van den Brink · 2015 · Annual Review of Immunology · 864 citations

Interleukin-22 (IL-22) is a recently described IL-10 family cytokine that is produced by T helper (Th) 17 cells, γδ T cells, NKT cells, and newly described innate lymphoid cells (ILCs). Knowledge o...

Reading Guide

Foundational Papers

Start with Yang et al. (2008; 1105 citations) for molecular antagonism basics, then Gaffen et al. (2014; 1477 citations) for IL-23/IL-17 psoriasis axis, followed by Ciofani et al. (2012; 1160 citations) for Th17 networks.

Recent Advances

Study Gagliani et al. (2015; 770 citations) for Th17-to-Treg transdifferentiation and Mills (2022; 825 citations) for IL-17 pathology in chronic settings.

Core Methods

Fate-mapping for lineage tracing (Gagliani 2015); ChIP-seq for epigenetics (Ciofani 2012); scRNA-seq for skin infiltrates (Lowes 2014, Eyerich 2009).

How PapersFlow Helps You Research IL-17 Producing T Cell Plasticity

Discover & Search

Research Agent uses citationGraph on Gaffen et al. (2014; 1477 citations) to map IL-23/IL-17 axis papers, then findSimilarPapers reveals 50+ on Th17 plasticity like Gagliani et al. (2015). exaSearch queries 'Th17 transdifferentiation psoriasis' for 2022+ works beyond Mills (2022). searchPapers with 'IL-17 T cell plasticity epigenetic' uncovers Lowes et al. (2014) psoriasis links.

Analyze & Verify

Analysis Agent applies readPaperContent to extract plasticity mechanisms from Yang et al. (2008), then verifyResponse with CoVe cross-checks claims against Ciofani et al. (2012) regulatory networks. runPythonAnalysis processes single-cell data from Eyerich et al. (2009) Th22 subsets using pandas for cytokine co-expression stats. GRADE grading scores evidence strength for Gagliani et al. (2015) transdifferentiation in inflammation resolution.

Synthesize & Write

Synthesis Agent detects gaps in Th17-to-Treg pathways post-Gagliani et al. (2015), flags contradictions between Yang et al. (2008) antagonism and Lee et al. (2009) late plasticity. Writing Agent uses latexEditText for figure legends, latexSyncCitations integrates 10 papers, latexCompile generates psoriasis T cell diagrams, exportMermaid visualizes lineage switches.

Use Cases

"Analyze scRNA-seq data from Th17 plasticity papers for psoriasis cytokine shifts"

Research Agent → searchPapers('Th17 scRNA-seq psoriasis') → Analysis Agent → runPythonAnalysis(pandas clustering on Eyerich et al. 2009 data) → researcher gets matplotlib heatmaps of IL-17/IL-22 co-expression trajectories.

"Draft LaTeX review on IL-17 T cell plasticity in psoriasis therapeutics"

Synthesis Agent → gap detection (post-Gaffen 2014) → Writing Agent → latexEditText(structure sections) → latexSyncCitations(10 papers) → latexCompile → researcher gets PDF with cited Th17 diagrams.

"Find code for modeling Th17 transdifferentiation from recent papers"

Research Agent → paperExtractUrls(Ciofani 2012) → paperFindGithubRepo → githubRepoInspect → researcher gets Python scripts for regulatory network simulations linked to Th17 specification.

Automated Workflows

Deep Research workflow scans 50+ papers via citationGraph from Lowes et al. (2014), structures Th17 plasticity report with GRADE-scored sections on psoriasis pathogenesis. DeepScan's 7-step chain verifies Gagliani et al. (2015) claims with CoVe against Mills (2022), checkpointing epigenetic drivers. Theorizer generates hypotheses on IL-23 plasticity blockade from Yang et al. (2008) antagonism data.

Try Doxa for IL-17 Producing T Cell Plasticity Research

Frequently Asked Questions

What defines IL-17 producing T cell plasticity?

It is the ability of Th17 cells to transdifferentiate into Treg, Tr1, Tfh, or cytotoxic cells via epigenetic changes under inflammatory signals like IL-23 and TGF-β (Gagliani et al., 2015).

What methods study Th17 plasticity?

Fate-mapping tracks Th17-to-Treg shifts (Gagliani et al., 2015); ChIP-seq maps regulatory networks (Ciofani et al., 2012); scRNA-seq profiles psoriasis infiltrates (Lowes et al., 2014).

What are key papers on this topic?

Gaffen et al. (2014; 1477 citations) on IL-23/IL-17 axis; Yang et al. (2008; 1105 citations) on program antagonism; Gagliani et al. (2015; 770 citations) on Th17-to-Treg conversion.

What open problems exist?

Human psoriasis-specific plasticity triggers unclear; therapeutic targeting of late plasticity untested (Lee et al., 2009; Mills, 2022); resistance mechanisms via subset switching need models.